The state of Texas currently has 65 active clinical trials seeking participants for Healthy research studies. These trials are conducted in various cities, including Houston, Dallas, San Antonio and Austin.
Metabolic Effects of Fructose Intake
Recruiting
The goal of this clinical trial is to learn how fructose ingestion affects metabolic factors in healthy adults aged 18-64, with a BMI between 19 and 30 kg/m², of any sex or gender. Specifically, the study aims to examine the impact of fructose compared to glucose on circulating metabolic factors including the soluble leptin receptor. The main questions it aims to answer are: How does fructose ingestion influence levels of circulating metabolic markers, including the soluble leptin receptor? Do... Read More
Gender:
ALL
Ages:
Between 18 years and 64 years
Trial Updated:
12/03/2024
Locations: Baylor St. Luke's Medical Center, Houston, Texas
Conditions: Healthy
Study to Assess Drug Levels and Safety of Golcadomide (BMS-986369) in Healthy Participants and Participants With Different Degrees of Hepatic Impairment
Recruiting
The purpose of this study is to assess the drug levels and safety of golcadomide (BMS-986369) in adult participants with moderate and severe Hepatic Impairment (HI), and in matched healthy control participants with normal hepatic function.
Gender:
ALL
Ages:
Between 18 years and 75 years
Trial Updated:
11/01/2024
Locations: Local Institution - 0006, San Antonio, Texas +1 locations
Conditions: Hepatic Impairment, Healthy Volunteers
The Modulatory Effect of Female Sex Hormones on Spinal Neuroplasticity
Recruiting
The goal of this project is to test our central hypothesis that the spinal cord neuroplasticity in females will be modulated by the level of estradiol concentration. under aim 1 we will determine the influence of estradiol fluctuations on spinal circuit excitability post afferent (sensory) mediated subthreshold motor priming in young healthy females and males. We will use an established repetitive peripheral nerve electrical stimulation with a stimulation intensity below the motor threshold to p... Read More
Gender:
ALL
Ages:
Between 18 years and 39 years
Trial Updated:
10/21/2024
Locations: University of Texas Southwestern Medical Center, Dallas, Texas
Conditions: Healthy
Single and Multiple Ascending Dose Study in Healthy Participants and Participants With an Autoimmune Disease
Recruiting
The main purpose of this study is to to evaluate the safety, tolerability, pharmacokinetics (PK), pharmacodynamics (PD), immunogenicity of LAD191 in healthy adults and in adults with an autoimmune disease.
Gender:
ALL
Ages:
Between 18 years and 65 years
Trial Updated:
10/16/2024
Locations: ICON Early Phase Services, LLC, San Antonio, Texas
Conditions: Healthy Volunteers, Autoimmune Disease
Study of Ciraparantag for Reversal of Anticoagulation Induced by Edoxaban, Apixaban or Rivaroxaban in Healthy Adults
Recruiting
A randomized, double-blind, placebo-controlled study to evaluate the efficacy and safety of ciraparantag for reversal of anticoagulation induced by different anticoagulant drugs in generally healthy adults as measured primarily by an automated coagulometer device.
Gender:
ALL
Ages:
Between 18 years and 75 years
Trial Updated:
08/09/2024
Locations: ICON Early Phase Services, LLC, San Antonio, Texas
Conditions: Healthy
Balance Control and Recovery in Diabetes Peripheral Neuropathy
Recruiting
In this study the effects of diabetic peripheral neuropathy will be assessed on balance control, balance recovery, and muscle electrical activity in adults over 50 years. Aim 1: Determine muscle activity and balance control during a sit-to-stand in adults age above 50 with and without diabetic peripheral neuropathy. Aim 2: Assess local balance recovery and latency responses to lateral surface perturbation during quiet standing.
Gender:
ALL
Ages:
Between 50 years and 99 years
Trial Updated:
08/05/2024
Locations: The University of Texas at Austin, Austin, Texas
Conditions: Diabetic Peripheral Neuropathy, Diabetic Peripheral Neuropathy Type 2, Diabetic Peripheral Neuropathy Type 2 - Uncontrolled, Healthy Aging
A Study to Evaluate Safety, Tolerability and Pharmacokinetics of MKND-201 in Healthy Volunteers
Recruiting
MKC-NI-001 is a Phase 1, first-in-human, randomized, double-blind, placebo-controlled study of nintedanib inhalation powder (MNKD-201) in healthy adult volunteers. The trial consists of a Single Ascending Dose (SAD), followed by a Multiple Ascending Dose (MAD) with a primary objective to evaluate the safety, tolerability, and pharmacokinetics (PK) of MNKD-201 compared to placebo in healthy adult participants.
Gender:
ALL
Ages:
Between 40 years and 65 years
Trial Updated:
08/02/2024
Locations: Flourish Research, San Antonio, Texas
Conditions: Healthy Volunteers
PODER Familiar: Health Promotion for Latino Families of Children With IDD
Recruiting
The goal of this clinical trial is to test a culturally tailored health promotion intervention for children with IDD and their families. First investigators will conduct a single group design pilot study of a health promotion intervention, followed by second, a small-scale randomized control trial (RCT). of the intervention with Latino parents of children with intellectual and developmental disabilities (IDD) in the Chicago, Illinois and Austin, Texas areas. The following research questions will... Read More
Gender:
ALL
Ages:
Between 6 years and 100 years
Trial Updated:
07/25/2024
Locations: Steve Hicks School of Social Work, University of Texas at Austin, Austin, Texas
Conditions: Health-Related Behavior, Quality of Life, Psychological Distress, Diet, Healthy, Physical Inactivity
Echography Study_Anthropometric Measurements
Recruiting
This is a multi-center, exploratory, estimation study in both adult and pediatric populations. There is no investigational product injection during this study The exploratory objective of this study is to evaluate the anatomical characteristics of both anterolateral thighs in healthy adult and healthy pediatric populations (2 to 17 years old) by ultrasound scan before and while applying a force similar to the ZENEO® triggering force. In the healthy adult population, anatomical characteristics o... Read More
Gender:
ALL
Ages:
Between 2 years and 70 years
Trial Updated:
07/19/2024
Locations: Clinical Trials of Texas, LLC dba Flourish Research, San Antonio, Texas
Conditions: Healthy Subjects
A Study to Assess the Drug Levels of Repotrectinib in Healthy Participants and Participants With Moderate and Severe Hepatic Impairment
Recruiting
The purpose of this study is to assess the drug levels of a single oral dose of repotrectinib in participants with moderate and severe HI, and in healthy matched control participants with normal hepatic function.
Gender:
ALL
Ages:
Between 18 years and 75 years
Trial Updated:
07/10/2024
Locations: Local Institution - 0004, San Antonio, Texas +1 locations
Conditions: Hepatic Impairment, Healthy Volunteers
Fluid Loading Countermeasures
Recruiting
The purpose of Fluid Loading Countermeasures is to determine how the volume of blood and of plasma (liquid part of blood) change during a normal day, how these are affected by drinking an additional amount of fluid either as water and salt tablets (as astronauts do) or an electrolyte beverage (similar to but tastes saltier than Gatorade®), and how altering the timing at which the additional fluid is consumed affects blood and plasma volume. This study observes how blood volume changes over \~9 h... Read More
Gender:
ALL
Ages:
Between 25 years and 55 years
Trial Updated:
07/08/2024
Locations: NASA, Houston, Texas
Conditions: Healthy
Gamma Oscillations as a Prognostic Marker for Ketamine Therapy in Treatment Resistant Depression
Recruiting
The core objective of this study is to enhance the translational potential of this electroencephalogram (EEG) biomarker by using ketamine(KET)-induced gamma potentiation as a prognostic marker of 4-week treatment outcome. Previous research focused exclusively on KET-induced gamma band potentiation (GBP) in the context of a single infusion. Our study design captures the clinical variation associated with real-world treatment resistant depression (TRD) patients and allows us to analyze the relativ... Read More
Gender:
ALL
Ages:
Between 21 years and 45 years
Trial Updated:
06/24/2024
Locations: Wells Medicine, Houston, Texas +1 locations
Conditions: Healthy, Major Depressive Disorder, Treatment Resistant Depression